Data / Form D filings / Cytonus Therapeutics, Inc.
Cytonus Therapeutics, Inc.: Form D filings
Cytonus Therapeutics, Inc., a biotechnology company in Carlsbad, CA, filed 5 Form D notices with the SEC between 2018 and 2023. The latest, on November 6, 2023, reports $11.7 million sold of a $21.6 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3280 Grey Hawk Ct., Carlsbad, CA, 92010
- Phone
- (631) 258-4070
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1761468
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | New notice | $21,603,089 | $11,703,095 | $9,899,994 | 19 | Oct 27, 2023 | sec.gov |
| Feb 10, 2022 | New notice | $1,000,000 | $15,000 | $985,000 | 1 | Jan 29, 2022 | sec.gov |
| Mar 18, 2021 | New notice | $5,000,000 | $2,500,000 | $2,500,000 | 1 | Mar 5, 2021 | sec.gov |
| Apr 30, 2020 | New notice | $1,000,000 | $100,000 | $900,000 | 2 | Apr 21, 2020 | sec.gov |
| Dec 26, 2018 | New notice | $3,000,000 | $70,000 | $2,930,000 | 2 | Dec 17, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Remo Moomiaie | Executive Officer, Director | |
| Richard Klemke | Executive Officer, Director | |
| Jae An | Director | |
| Christopher Thorne | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 6, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cytonus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.